Life After Cancer

 This article is from the ACS Website.

"When cancer treatment ends, people begin a new chapter in their lives, one that can bring hope and happiness, but also worries and fear."

Read more...

Treating ovarian cancer with anti-angiogenic agents

Ovacome shares videos from its Staying Connected webinars. Click here to watch the webinar on current research into treating ovarian cancer with anti-angiogenic agents, such as a bevacizumab, presented by Professor Gordon Jayson, BM, BA, Bch, FRCP, PhD, professor of oncology at The Christie in Manchester, England. 

What really matters at the end of life

TED TALK

At the end of our lives, what do we most wish for? For many, it's simply comfort, respect, love. B J Miller is a palliative care physician who thinks deeply about how to create a dignified, graceful and of life for his patients.

Watch video...

Inspired Advice: How Do You Keep from Feeling Isolated?

 

This article was posted on the OCRA website on May 27, 2021.       \

"When COVID-19 swept across the globe, self-isolation became a new reality for many. But as pandemic-related restrictions have started to lift, those living with ovarian cancer may still find themselves struggling with feelings of isolation. It’s not uncommon to experience these emotions at any stage of a gynecologic cancer, from diagnosis to treatment and beyond. But there are ways to cope. Read on to get advice from others who have found ways to keep from feeling alone."

Read more...

Adjusting to Life with Cancer

This article is from the ACS Website.

"A diagnosis of cancer impacts many parts of your life – whether you have just found out you have cancer, are getting treated, or have finished treatment. You likely feel both physical and emotional changes which can impact the way you feel and how you live. These changes may affect daily life, but there are ways to cope." 

Read more...

OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations

 

This article was posted on the OCRA website on June 30, 2021.     

"A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in laboratory cell lines and tumor models with BRCA1 or BRCA2 genetic mutations–and is effective even in tumors that have become resistant to PARP inhibitors."

Read more...

How is Immunotherapy for Ovarian Cancer Changing the Outlook for Patients?

This article was written by a team at Memorial Sloan Kettering Center and reviewed by Dmitriy Zamarin, M.D., Ph.D.

"Immunotherapy for ovarian cancer shows tremendous potential for addressing this devastating disease and several clinical trials testing new treatments are currently underway."

Read more...

Have questions about ovarian cancer research, treatment and care?

The ovarian cancer research alliance annual conference will be a virtual event again this year (September 28-30, 2021). Event coordinators invite your questions for their panel of experts.

To learn more or to register for the virtual conference, Click here.